Delivery Order SPE2DB22D2005-SPE2DB25FJEA6

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REXULTI 1 mg tablets. The $19,503.45 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,866.33 Firm Fixed Price Delivery Order contract has an ultimate completion date of December 11, 2024 and provides the REXULTI 4 MG TABLET 30S pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,472.99 firm fixed-price delivery order is for REXULTI 2 MG TABLET 30S and has an ultimate completion date of April 2, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,964.13 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for $6,259.29. The contract is a Firm Fixed Price Delivery Order for the pharmaceutical product REXULTI 1 MG TABLET 30S, with a period of performance through January 16, 2025. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,609.78 Firm Fixed Price Delivery Order contract is for the supply of 4567826491 REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,052.69, is a delivery order for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2024 and is a firm fixed-price contract. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,027.26, is a delivery order issued by the Defense Logistics Agency (DLA) as part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC runs through November 2026 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, is for the supply of REXULTI 1 MG TABLET 30S prescription medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,326.58 firm fixed price delivery order does not have a set-aside designation. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,891.25 delivery order contract is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJEA6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $10,497.08 firm-fixed-price delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DB26FJEA6. The contract provides for the delivery of REXULTI 2 MG TABLET 30S, a specialty pharmaceutical product, with a completion date of October 25, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a significant vendor for the DLA, holding a $999,999,999 IDC that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 1/23/25, 9:37 AM